Journal of Ophthalmic & Vision Research最新文献

Effect of Occupational Exposure to Low-frequency Electromagnetic Fields on Cataract Development. 职业接触低频电磁场对白内障发展的影响。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2025-04-25 eCollection Date: 2025-04-01 DOI: 10.18502/jovr.v20.12281

Mohammad Hosein Validad, Monireh Mahjoob, Masoud Pishjo, Mostafa Diani, Tahereh Rakhshandadi

{"title":"Effect of Occupational Exposure to Low-frequency Electromagnetic Fields on Cataract Development.","authors":"Mohammad Hosein Validad, Monireh Mahjoob, Masoud Pishjo, Mostafa Diani, Tahereh Rakhshandadi","doi":"10.18502/jovr.v20.12281","DOIUrl":"10.18502/jovr.v20.12281","url":null,"abstract":"Purpose: Cataracts are the second leading cause of visual impairment worldwide. This study aimed to examine the impact of occupational exposure to low-frequency electromagnetic fields on cataract development.Methods: One hundred employees of Zahedan Electricity Company participated in this study. They were assigned to four groups based on their level of exposure: regular, operational, operator personnel, and non-exposure. Based on LOCS III grading, the risk of developing different types of cataracts (i.e., nuclear, posterior subcapsular, and cortical) was evaluated for all participants.Results: The frequency of cataracts was 62.2% in the exposure group (which includes three subgroups: the regular, operational, and operator personnel) and 53.8% in the non-exposure group. There was a significant difference between the study groups in terms of nuclear opacity grading (P = 0.003). The correlation between nuclear and posterior subcapsular cataract grading and work experience duration in the exposure group was statistically significant (P <math><mo><</mo></math> 0.018).Conclusion: This study's findings indicate that exposure to low-frequency electromagnetic fields such as power lines, power plants, and power distribution posts may be a risk factor for cataract development, particularly nuclear cataracts.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"20 ","pages":"1-6"},"PeriodicalIF":1.6,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12094108/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144119907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Clinical Practice, Challenges, and the Future of Ophthalmic Genetics in Saudi Arabia. 沙特阿拉伯眼科遗传学的临床实践、挑战和未来。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2025-04-02 eCollection Date: 2024-04-01 DOI: 10.18502/jovr.v20.15890

Basamat AlMoallem, Ghadah Alsuwailem, Nadeef Alqahtani, Layan Alshammari, Abeer Alkhodier

{"title":"Clinical Practice, Challenges, and the Future of Ophthalmic Genetics in Saudi Arabia.","authors":"Basamat AlMoallem, Ghadah Alsuwailem, Nadeef Alqahtani, Layan Alshammari, Abeer Alkhodier","doi":"10.18502/jovr.v20.15890","DOIUrl":"https://doi.org/10.18502/jovr.v20.15890","url":null,"abstract":"Purpose: Ophthalmic genetics is vital for diagnosing and managing inherited eye disorders, contributing to personalized treatments.Methods: This cross-sectional study assessed 131 healthcare professionals in Saudi Arabia through an online questionnaire to evaluate clinical practices, referral patterns, and challenges in genetic ophthalmology.Results: Our study showed that 61.7% of participants reported the availability of ophthalmic genetics services in their hospitals, with an equal percentage referring patients to genetic specialists. However, significant barriers were identified, including limited budgets for genetic testing (69.6%), a lack of trained physicians (70.9%), low community awareness (50.6%), and a perceived lack of treatment options (27.8%). Additionally, concerns about patient access to genetic testing (54.3%) and genetic counseling (50.6%) were highlighted.Conclusion: This is the first study on ophthalmic genetics in Saudi Arabia, and its findings emphasize the need for policy reforms and targeted interventions. Proposed solutions include innovative financial models for genetic testing, expanded training programs for healthcare providers, and public awareness campaigns to improve access to genetic services. Addressing these challenges can enhance early diagnosis, treatment strategies, and patient outcomes in ophthalmic genetics.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"20 ","pages":"1-8"},"PeriodicalIF":1.6,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12013457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144025902","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Presumed Tubercular Multifocal Choroiditis. 推测为结核性多灶性脉络膜炎。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.11199

Masoud Soheilian, Pejvak Azadi

引用次数: 0

Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops. 1.25%匹罗卡品滴眼液治疗老花眼的药理作用。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.14578

Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli-Mofrad, Kourosh Sheibani, Hemn Baghban Jaldian

{"title":"Pharmacological Treatment of Presbyopia Using Pilocarpine 1.25% Eye Drops.","authors":"Seyed Abolghasem Mousavi, Zhale Rajavi, Hamideh Sabbaghi, Saeid Abdi, Nafeeseh Montazerin, Bahareh Kheiri, Azadeh Haseli-Mofrad, Kourosh Sheibani, Hemn Baghban Jaldian","doi":"10.18502/jovr.v19i4.14578","DOIUrl":"10.18502/jovr.v19i4.14578","url":null,"abstract":"Purpose: To assess the efficiency and safety of pilocarpine eye drop 1.25% analogue (IR- Pilo) in comparison with its original brand-name drug (Vuity).Methods: In this non-randomized comparative study, 75 patients with presbyopia aged 40 to 60 years were enrolled. The right eyes of these patients received either IR-Pilo (n = 45) or Vuity (n = 30) and their contralateral eyes served as controls. Refractive errors, distance best-corrected visual acuity (BCVA), near vision, amplitude of accommodation, pupil size, and intraocular pressure (IOP) were measured before and 1 to 2 hours after instillation of the eye drop.Results: The mean refractive error was stable, except for a small myopic shift in the Vuity group. There was no significant change in distance BCVA. Near vision improved significantly in both intervention groups (P <math><mo><</mo></math> 0.001) with preference for IR-Pilo (4 vs 2.3). Furthermore, a higher amplitude of accommodation and pupil constriction occurred after instillation of both drops, with a higher effect associated with IR-Pilo. However, IOP did not change significantly post intervention.Conclusion: IR-Pilo and Vuity eye drops had comparable results; both were effective and led to stable distance vision and improved near vision. Both ophthalmic drugs were safe and none of them were associated with significant adverse effects.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"468-475"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795009/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Long-term Results of Topical Insulin Treatment for Persistent Corneal Epithelial Defects. 外用胰岛素治疗持续性角膜上皮缺损的远期疗效。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.13977

Júlio Almeida, Tomás R Costa, Maria Vivas, Catarina Monteiro, Fernando T Vaz, Diana Silva, Cristina Vendrell, Isabel Prieto

{"title":"Long-term Results of Topical Insulin Treatment for Persistent Corneal Epithelial Defects.","authors":"Júlio Almeida, Tomás R Costa, Maria Vivas, Catarina Monteiro, Fernando T Vaz, Diana Silva, Cristina Vendrell, Isabel Prieto","doi":"10.18502/jovr.v19i4.13977","DOIUrl":"10.18502/jovr.v19i4.13977","url":null,"abstract":"Purpose: To evaluate the effects of topical insulin in patients with persistent corneal epithelial defects that are refractory to the standard treatment.Methods: A retrospective, hospital-based, clinical study was performed on 17 eyes of 16 patients with different types of refractory persistent epithelial defects who were treated with topical insulin. The treatment was continued until the defect either was resolved or persisted after three months. Patients' demographic information, etiology, comorbidities, and clinical data were reviewed. The rate of epithelial healing was considered as the primary outcome measure.Results: Neurotrophic keratitis was the most common cause of persistent epithelial defects (58.8%), and within this category, herpetic eye disease was the main comorbidity (44.4%). The mean follow-up time was 17.91 months. Eleven out of fifteen eyes (77.3%) had complete improvement and only one patient did not respond to the treatment. The mean time of reepithelization for the eyes with full recovery was 31.27 days (ranging from 6 to 61 days). The best-corrected visual acuity improved significantly after treatment (P <math><mo><</mo></math> 0.005), and there were no reports of complications or side effects during the study period.Conclusion: Our results suggest that topical insulin, due to its good safety profile, availability, and affordability, could be a good therapeutic alternative for persistent epithelial defects.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"397-404"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

New Sight for Old: Commentary On the Use of Pilocarpine for Presbyopia. 以旧换新：匹罗卡品治疗老花眼述评。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.17786

Cameron F Parsa

引用次数: 0

Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma. 高眼压和青光眼的血清氧化应激相关生物标志物。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.15011

Mine Esen Baris, Onur Furundaoturan, Meltem Kocamanoğlu, Seray Şahin, Yasemin Akçay, Suzan Güven Yılmaz

{"title":"Serum Oxidative Stress-related Biomarkers in Ocular Hypertension and Glaucoma.","authors":"Mine Esen Baris, Onur Furundaoturan, Meltem Kocamanoğlu, Seray Şahin, Yasemin Akçay, Suzan Güven Yılmaz","doi":"10.18502/jovr.v19i4.15011","DOIUrl":"10.18502/jovr.v19i4.15011","url":null,"abstract":"Purpose: To evaluate the serum levels of oxidative stress-related molecules in patients with ocular hypertension (OHT) and primary open-angle glaucoma (POAG) compared with healthy controls.Methods: Treatment-naive patients with no known systemic diseases and with OHTand POAG diagnosis were recruited for the study. Also, age- and gender-matched healthy volunteers with no ocular and systemic diseases were included as controls. None of the participants were under any topical or systemic treatment or vitamin/antioxidant supplements. Smokers were excluded from the study. Serum levels of total antioxidant capacity (TAC), ascorbic acid, protein carbonyls (PCs), advanced glycation end products (AGEs), neuronal pentraxin 2 (NPTX2), and <math><mi>β</mi></math> -amyloid precursor protein(A <math><mi>β</mi></math> ) were analyzed.Results: A total of 90 patients (30 in each group) were included in the study. There was no statistically significant difference between the study groups in terms of age and gender distribution. Serum levels of TAC (1.47 <math><mo>±</mo></math> 0.11 mmole/L) were significantly higher in patients with OHT compared to controls (1.40 <math><mo>±</mo></math> 0.11 mmole/L) and patients with POAG (1.30 <math><mo>±</mo></math> 0.08 mmole/L) (P <math><mo><</mo></math> 0.05). However, there was no significant difference between the study groups in terms of serum levels of ascorbic acid, PCs, AGEs, NPTX2, and A <math><mi>β</mi></math> .Conclusion: Serum levels of TAC were significantly higher in patients with OHT. This elevated level might contribute to the protection of the optic nerve even in the presence of increased intraocular pressure.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"433-439"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Sequential Serous Choroidal Detachment in Subjects Undergoing Bilateral Trabeculectomy. 接受双侧小梁切除术的受试者的顺序浆液性脉络膜脱离。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.13881

Maryam Yadgari, Kiana Hassanpour, Fatemeh Vafaei, Nina Firoozian, Maryam Oraee Yazdani, Zahra Khorrami, Sadid Hooshmandi

{"title":"Sequential Serous Choroidal Detachment in Subjects Undergoing Bilateral Trabeculectomy.","authors":"Maryam Yadgari, Kiana Hassanpour, Fatemeh Vafaei, Nina Firoozian, Maryam Oraee Yazdani, Zahra Khorrami, Sadid Hooshmandi","doi":"10.18502/jovr.v19i4.13881","DOIUrl":"10.18502/jovr.v19i4.13881","url":null,"abstract":"Purpose: This study aims to assess the incidence of serous choroidal detachment (SCD) in the second eye of patients undergoing bilateral trabeculectomy (BT) and evaluate its impact on the clinical outcomes and failure rate of trabeculectomy in the second-operated eyes.Methods: This retrospective case-control study analyzed 90 eyes of 45 patients who underwent BT. Surgical success was defined as maintaining intraocular pressure (IOP) between 5 and 21 mmHg, requiring no additional glaucoma surgery, and exhibiting a visual acuity of at least light perception. Relevant patient data, such as age, glaucoma type, systemic diseases, preoperative and postoperative IOP, and complications, were extracted from medical records.Results: The mean age of patients was 59.8 <math><mo>±</mo></math> 11.1 years. The five-year cumulative probability of success in the first- and second-operated eyes was 61.0% and 67.6%, respectively (log rank = 0.085, P = 0.77). Among the participants, 28.9% experienced SCD, and 76.9% of those who had SCD in the first-operated eye developed the same condition in the second eye as well (P <math><mo><</mo></math> 0.001). In the first-operated eyes, the five-year cumulative probability of survival was 71.7% without SCD and 35.0% with SCD (log rank = 2.59, P = 0.107).Conclusion: The occurrence of SCD in the first eye following trabeculectomy may indicate a predisposition to its development in the second eye during BT. Furthermore, the surgical success rate of the second-operated eye is comparable to the outcomes of the first eye undergoing BT.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"421-432"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795004/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effect of Collagen Cross-linking on Rigid Gas Permeable Contact Lens Comfort in Keratoconus. 胶原交联对圆锥角膜硬性透气性隐形眼镜舒适度的影响。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.10891

Sharafat Javaheri, Mahmood Nejabat, Asieh Ehsaei, Sahar Mohaghegh, Zahra Tajbakhsh

{"title":"Effect of Collagen Cross-linking on Rigid Gas Permeable Contact Lens Comfort in Keratoconus.","authors":"Sharafat Javaheri, Mahmood Nejabat, Asieh Ehsaei, Sahar Mohaghegh, Zahra Tajbakhsh","doi":"10.18502/jovr.v19i4.10891","DOIUrl":"10.18502/jovr.v19i4.10891","url":null,"abstract":"Purpose: To compare rigid gas permeable (RGP) contact lens comfort in patients with keratoconus who underwent corneal cross-linking (CXL) versus those without CXL surgery.Methods: This prospective study was carried out on 41 eyes (25 patients). Specifically, 21 eyes were assigned to the CXL group and 20 eyes to the non-CXL group. All of the patients were fitted with RGP lenses. The patients were also assessed one and three months after the initial RGP fitting. They were asked to grade themselves on a scale from 1 to 4 according to the frequency and intensity of ocular discomfort, vision fluctuation, and overall comfort with RGP lenses.Results: The mean age of participants was 24.5 <math><mo>±</mo></math> 3.20 years. There was no significant difference in the intensity of fluctuations in vision (P = 0.30), frequency of discomfort (P = 0.29), and intensity of discomfort (P = 0.31) between the two groups during the one- and three-month follow-up interviews.Conclusion: Based on the current study, there is no significant disparity in self-reported discomfort with RGP contact lenses between patients with keratoconus who have undergone corneal CXL and those who have not.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"405-412"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795010/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Choroidal and Retinal OCTA Parameters after Scleral Buckling. 巩膜屈曲后脉络膜和视网膜OCTA参数。

IF 1.6

Journal of Ophthalmic & Vision Research Pub Date : 2024-12-31 eCollection Date: 2024-12-01 DOI: 10.18502/jovr.v19i4.14432

Siamak Moradian, Mahmoud Dehghan, Morteza Borandeh Seifi, Mohsen Dastmardi, Fatemeh Suri

{"title":"Choroidal and Retinal OCTA Parameters after Scleral Buckling.","authors":"Siamak Moradian, Mahmoud Dehghan, Morteza Borandeh Seifi, Mohsen Dastmardi, Fatemeh Suri","doi":"10.18502/jovr.v19i4.14432","DOIUrl":"10.18502/jovr.v19i4.14432","url":null,"abstract":"Purpose: To evaluate choroidal structure and vasculature in eyes following scleral buckling (SB) for rhegmatogenous retinal detachment (RRD) compared with fellow eyes and control eyes.Methods: This retrospective observational study was performed on 84 eyes: 32 eyes in the study group consisting of patients who had undergone SB due to RRD, 32 fellow eyes of the same patients, and 20 normal control eyes. Choroidal structures and optical coherence tomography angiography (OCTA) parameters were measured and compared among the three study groups.Results: In the study group, the mean total choroidal area (0.6816 <math><mo>±</mo></math> 0.03188 mm2) was comparable to the fellow eyes (0.7199 <math><mo>±</mo></math> 0.03056 mm2) and the control group (0.7154 <math><mo>±</mo></math> 0.17160 mm2). Mean outer luminal area was significantly lower in the study group (0.4089 <math><mo>±</mo></math> 0.00442 mm2) than in the fellow eyes (0.4437 <math><mo>±</mo></math> 0.00701 mm2) and the control group (0.4475 <math><mo>±</mo></math> 0.00442 mm2) (P = 0.042, and 0.047, respectively). The choroidal vascularity index (CVI) and OCTA parameters were not significantly different in eyes with prior SB compared to the fellow eyes and the control group.Conclusion: SB does not significantly affect CVI, choroidal vasculature, and OCTA parameters.","PeriodicalId":16586,"journal":{"name":"Journal of Ophthalmic & Vision Research","volume":"19 4","pages":"440-448"},"PeriodicalIF":1.6,"publicationDate":"2024-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11795003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143364541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0